NO20015751L - Nevrotrofiske faktorer i behandlingen av perifer nervedysfunksjon i bekkenområdet - Google Patents
Nevrotrofiske faktorer i behandlingen av perifer nervedysfunksjon i bekkenområdetInfo
- Publication number
- NO20015751L NO20015751L NO20015751A NO20015751A NO20015751L NO 20015751 L NO20015751 L NO 20015751L NO 20015751 A NO20015751 A NO 20015751A NO 20015751 A NO20015751 A NO 20015751A NO 20015751 L NO20015751 L NO 20015751L
- Authority
- NO
- Norway
- Prior art keywords
- surgery
- neurotrophic factors
- proteins
- treatment
- pelvic
- Prior art date
Links
- 108010025020 Nerve Growth Factor Proteins 0.000 title abstract 3
- 102000007072 Nerve Growth Factors Human genes 0.000 title abstract 3
- 230000004064 dysfunction Effects 0.000 title abstract 3
- 239000003900 neurotrophic factor Substances 0.000 title abstract 3
- 210000005036 nerve Anatomy 0.000 title 1
- 238000001356 surgical procedure Methods 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940127554 medical product Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 210000000578 peripheral nerve Anatomy 0.000 abstract 1
- 208000033808 peripheral neuropathy Diseases 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 230000001228 trophic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI991197A FI991197A0 (fi) | 1999-05-27 | 1999-05-27 | Neurotrooppiset tekijät lantionalueen ääreishermoston toimintahäiriön hoitamisessa |
| PCT/FI2000/000476 WO2000072871A1 (en) | 1999-05-27 | 2000-05-26 | Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20015751D0 NO20015751D0 (no) | 2001-11-26 |
| NO20015751L true NO20015751L (no) | 2001-12-20 |
Family
ID=8554739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20015751A NO20015751L (no) | 1999-05-27 | 2001-11-26 | Nevrotrofiske faktorer i behandlingen av perifer nervedysfunksjon i bekkenområdet |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1181042B8 (de) |
| JP (1) | JP2003500455A (de) |
| KR (1) | KR20020016805A (de) |
| CN (1) | CN1365285A (de) |
| AT (1) | ATE378061T1 (de) |
| AU (1) | AU776275B2 (de) |
| CA (1) | CA2373726A1 (de) |
| DE (1) | DE60037111T2 (de) |
| ES (1) | ES2295027T3 (de) |
| FI (1) | FI991197A0 (de) |
| IL (1) | IL146346A0 (de) |
| NO (1) | NO20015751L (de) |
| NZ (1) | NZ515379A (de) |
| WO (1) | WO2000072871A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1365794A2 (de) | 2000-07-21 | 2003-12-03 | Lue, Tom | Vorbeugung und behandlung von störungen der sexuellen erregbarkeit |
| US7223406B2 (en) | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| JP2009525319A (ja) | 2006-02-02 | 2009-07-09 | ライナット ニューロサイエンス コーポレイション | ｔｒｋＢアンタゴニストを投与することにより肥満を治療する方法 |
| TW201034684A (en) * | 2009-02-18 | 2010-10-01 | Genentech Inc | Method for inhibiting neurodegeneration |
| DE102011051868B4 (de) * | 2011-07-15 | 2013-02-21 | ITM Isotopen Technologien München AG | Verfahren zur Herstellung trägerfreier hochreiner 177Lu-Verbindungen sowie trägerfreie 177Lu-Verbindungen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2109598A1 (en) * | 1991-05-21 | 1992-11-26 | Finn Hallbook | Therapeutic and diagnostic methods based on neurotrophin-4- expression |
| DE69732350T2 (de) * | 1996-03-14 | 2005-12-22 | Washington University | Persephin und verwandte wachstumsfaktoren |
| WO1998002178A1 (en) * | 1996-07-12 | 1998-01-22 | Massachusetts Institute Of Technology | Methods of controlling axonal growth |
| CA2279577A1 (en) * | 1997-02-04 | 1998-08-06 | Valentis, Inc. | Treatment for urinary incontinence using gene therapy techniques |
| AU730430B2 (en) * | 1997-02-18 | 2001-03-08 | Genentech Inc. | Neurturin receptor |
-
1999
- 1999-05-27 FI FI991197A patent/FI991197A0/fi unknown
-
2000
- 2000-05-26 JP JP2000620979A patent/JP2003500455A/ja active Pending
- 2000-05-26 AU AU47610/00A patent/AU776275B2/en not_active Ceased
- 2000-05-26 ES ES00929587T patent/ES2295027T3/es not_active Expired - Lifetime
- 2000-05-26 CN CN00810917A patent/CN1365285A/zh active Pending
- 2000-05-26 CA CA002373726A patent/CA2373726A1/en not_active Abandoned
- 2000-05-26 IL IL14634600A patent/IL146346A0/xx unknown
- 2000-05-26 NZ NZ515379A patent/NZ515379A/en not_active IP Right Cessation
- 2000-05-26 AT AT00929587T patent/ATE378061T1/de not_active IP Right Cessation
- 2000-05-26 WO PCT/FI2000/000476 patent/WO2000072871A1/en not_active Ceased
- 2000-05-26 EP EP00929587A patent/EP1181042B8/de not_active Expired - Lifetime
- 2000-05-26 KR KR1020017015154A patent/KR20020016805A/ko not_active Ceased
- 2000-05-26 DE DE60037111T patent/DE60037111T2/de not_active Expired - Lifetime
-
2001
- 2001-11-26 NO NO20015751A patent/NO20015751L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2373726A1 (en) | 2000-12-07 |
| KR20020016805A (ko) | 2002-03-06 |
| AU4761000A (en) | 2000-12-18 |
| EP1181042B1 (de) | 2007-11-14 |
| NZ515379A (en) | 2004-04-30 |
| JP2003500455A (ja) | 2003-01-07 |
| EP1181042A1 (de) | 2002-02-27 |
| CN1365285A (zh) | 2002-08-21 |
| ATE378061T1 (de) | 2007-11-15 |
| NO20015751D0 (no) | 2001-11-26 |
| IL146346A0 (en) | 2002-07-25 |
| AU776275B2 (en) | 2004-09-02 |
| DE60037111D1 (de) | 2007-12-27 |
| ES2295027T3 (es) | 2008-04-16 |
| DE60037111T2 (de) | 2008-10-02 |
| WO2000072871A1 (en) | 2000-12-07 |
| FI991197A0 (fi) | 1999-05-27 |
| EP1181042B8 (de) | 2008-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9603484A2 (hu) | Gyógyászati készítmények és eljárás ingerületátvitel befolyásolására | |
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| WO2002041837A3 (en) | Treatment of mucositis | |
| IS7770A (is) | Hlutleysandi mótefni gegn GDF-8 og notkun theirra | |
| MD970227A (ro) | Dihidropirimidine şi utilizarea lor | |
| WO2002036732A3 (en) | Active variants of fgf with improved specificity | |
| MXPA02006885A (es) | Bloqueo del crecimiento axonal mediado por receptor de nogo. | |
| WO2004019884A3 (en) | Agents and methods for enhancing bone formation | |
| TR199903154T2 (xx) | Meme kanserinin tedavisi ve te�hisi i�in bile�imler ve y�ntemler | |
| TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
| DE69930662D1 (de) | Humane rezeptortyrosinkinase | |
| ATE214272T1 (de) | Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz | |
| ATE307203T1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
| NO20015751D0 (no) | Nevrotrofiske faktorer i behandlingen av perifer nervedysfunksjon i bekkenområdet | |
| WO1999056666A8 (en) | The treatment of sexual dysfunction in certain patient groups | |
| MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
| WO2000065028A3 (en) | TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR | |
| ATE255411T1 (de) | Hyaluronsäurerezeptoren bindende stoffe und deren verwendung zur behandlung von tumoren und restenose | |
| WO1999016406A3 (en) | Therapeutic method | |
| WO2001012127A3 (en) | TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR | |
| DE60122781D1 (de) | Neue therapeutische verwendung eines derivates von thienylcyclohexylamine zur behandlung von schmerzen | |
| Hayase et al. | A Case of Blunt Traumatic Arteriovenous Malformation of the Forearm | |
| MD1732F1 (en) | Method of prognosticating the duodenal ulcerous disease evolution | |
| ATE380884T1 (de) | Verwendung von mirtazapin zur verbesserung der behandlung von menschen mit starken depressionen, welche träger des gens für apolipoprotein e4 sind. | |
| UA47640U (uk) | Спосіб заміщення пострезекційних дефектів, що утворилися при сегментарній резекції кісткових кіст у дітей |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |